InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.046

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Application for quotation of securities - IMC 17 Jul 2025 9:44AM $0.065 $0.046 fallen by 29.23%
$15 FY25 global sales exceed projection, up 49% on prior year 17 Jul 2025 8:44AM $0.065 $0.046 fallen by 29.23%
$15 Proposed issue of securities - IMC 16 Jul 2025 12:59PM $0.065 $0.046 fallen by 29.23%
$15 Change in substantial holding 1 Jul 2025 8:27AM $0.061 $0.046 fallen by 24.59%
$15 Notice under section 708A 4 Jun 2025 8:32AM $0.067 $0.046 fallen by 31.34%
$15 Application for quotation of securities - IMC 4 Jun 2025 8:27AM $0.067 $0.046 fallen by 31.34%
$15 Proposed issue of securities - IMC 3 Jun 2025 4:39PM $0.067 $0.046 fallen by 31.34%
$15 Letter to Shareholders 30 May 2025 9:33AM $0.072 $0.046 fallen by 36.11%
$15 Notice under section 708A 30 May 2025 9:06AM $0.072 $0.046 fallen by 36.11%
$15 Application for quotation of securities - IMC 30 May 2025 9:01AM $0.072 $0.046 fallen by 36.11%
$15 Proposed issue of securities - IMC 29 May 2025 4:29PM $0.072 $0.046 fallen by 36.11%
$15 Notice under section 708A 11 Apr 2025 2:59PM $0.066 $0.046 fallen by 30.30%
$15 Notification of cessation of securities - IMC 11 Apr 2025 2:57PM $0.066 $0.046 fallen by 30.30%
$15 Application for quotation of securities - IMC 11 Apr 2025 2:56PM $0.066 $0.046 fallen by 30.30%
$15 Immuron Travelan highest sales in history 10 Apr 2025 11:20AM $0.060 $0.046 fallen by 23.33%
$15 Immuron CEO presentation to Coffee Microcaps Conference 7 Mar 2025 8:30AM $0.078 $0.046 fallen by 41.03%
$15 IMC and Calmino to treat Irritable Bowel Syndrome (IBS) 5 Mar 2025 9:50AM $0.078 $0.046 fallen by 41.03%
$15 Appendix 4D and Half Year Report 28 Feb 2025 5:48PM $0.080 $0.046 fallen by 42.50%
$15 Immuron CEO presentation to Emerging Growth Conference 19 Feb 2025 8:33AM $0.079 $0.046 fallen by 41.77%
$15 Notice under section 708A 17 Jan 2025 1:40PM $0.090 $0.046 fallen by 48.89%
$15 Application for quotation of securities - IMC 17 Jan 2025 1:27PM $0.090 $0.046 fallen by 48.89%
$15 Immuron Travelan continued strong sales growth 17 Jan 2025 10:29AM $0.086 $0.046 fallen by 46.51%
$15 Proposed issue of securities - IMC 15 Jan 2025 2:00PM $0.086 $0.046 fallen by 46.51%
$15 Immuron Announces Monash AMR Research Collaboration 15 Jan 2025 9:18AM $0.098 $0.046 fallen by 53.06%
$15 Immuron Announces Travelan Clinical Trial Update 14 Jan 2025 12:06PM $0.085 $0.046 fallen by 45.88%

101 - 125 of 782 results

Page 5 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.